PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
75.67%
Revenue growth above 1.5x ENPH's 6.15%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
139.12%
Gross profit growth above 1.5x ENPH's 7.73%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
505.40%
EBIT growth above 1.5x ENPH's 3.06%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
616.64%
Operating income growth above 1.5x ENPH's 3.06%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
320.55%
Positive net income growth while ENPH is negative. John Neff might see a big relative performance advantage.
329.17%
Positive EPS growth while ENPH is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
315.00%
Positive diluted EPS growth while ENPH is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.14%
Share reduction more than 1.5x ENPH's 1.12%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-1.82%
Reduced diluted shares while ENPH is at 0.45%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
477.41%
Positive OCF growth while ENPH is negative. John Neff would see this as a clear operational advantage vs. the competitor.
156.59%
Positive FCF growth while ENPH is negative. John Neff would see a strong competitive edge in net cash generation.
10938.99%
Positive 10Y revenue/share CAGR while ENPH is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
53.87%
Positive 5Y CAGR while ENPH is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
53.69%
3Y revenue/share CAGR at 75-90% of ENPH's 65.90%. Bill Ackman would expect new product strategies to close the gap.
4077.42%
10Y OCF/share CAGR above 1.5x ENPH's 104.16%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-4.71%
Negative 5Y OCF/share CAGR while ENPH is at 104.16%. Joel Greenblatt would question the firm’s operational model or cost structure.
-32.03%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
821.32%
Net income/share CAGR above 1.5x ENPH's 100.15% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
10067.98%
5Y net income/share CAGR above 1.5x ENPH's 100.15%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
220.60%
3Y net income/share CAGR above 1.5x ENPH's 106.54%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-19.49%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-10.49%
Negative 3Y equity/share growth while ENPH is at 27.83%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.06%
Our AR growth while ENPH is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
6.77%
Inventory shrinking or stable vs. ENPH's 39.40%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.43%
Negative asset growth while ENPH invests at 5.16%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
10.92%
1.25-1.5x ENPH's 9.35%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
7.10%
We have some new debt while ENPH reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
31.43%
R&D growth drastically higher vs. ENPH's 7.66%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.93%
SG&A growth well above ENPH's 8.25%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.